| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,381 | 5,781 | 6,270 | 6,685 | | Cost of Revenue | 2,007 | 1,803 | 2,050 | 2,345 | | | Gross Profit | 4,374 | 3,978 | 4,220 | 4,340 | | | Operating Expenses | | Research Development | 1,874 | 1,840 | 1,830 | 1,446 | | Selling General and Administrative | 3,603 | 3,572 | 3,454 | 3,681 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,103) | (1,434) | (1,064) | (787) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | 36 | (35) | (22) | | Earnings Before Interest And Taxes | (1,111) | (1,398) | (1,099) | (809) | | Interest Expense | 24 | 9 | 5 | 25 | | Income Before Tax | (1,135) | (1,407) | (1,104) | (834) | | Income Tax Expense | (295) | (320) | (226) | (591) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (840) | (1,087) | (878) | (243) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (840) | (1,087) | (878) | (243) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($840) | ($1,087) | ($878) | ($243) |
|
0.83% Nasdaq 0.00%
Income Statement
